510(k) Report

FDA applicant

Inneuroco, Inc.

Sunrise, FL9 decisions2016–20233 recalls

FDA records 9 decisions for Inneuroco, Inc. (Sunrise, FL) from 2016 to 2023: 9 510(k) clearances. Most are in product codes DQY (Catheter, Percutaneous) and NRY (Catheter, Thrombus Retriever). Since 2016 its 510(k)s took a median of 137 days from receipt to decision, against 113 for FDA’s reviews in the same codes and years. Its devices cite 10 predicates, 2 of them its own earlier devices. 3 recalls are linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, cardiovascular panel, where it files most

How often FDA has decided Inneuroco, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2023

2016: 12017: 22018: 32019: 12022: 12023: 1
2016high 3 (2018) · low 0 (2020)2026

2026 so far, outlined.

Recalls per year

3in 2019

2019: 3
2016high 3 (2019) · low 0 (2016)2026

Class I Class II/III not classified

FIG. 1 — Inneuroco, Inc. by year, 2016–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Inneuroco, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report